期刊
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
卷 12, 期 7, 页码 975-981出版社
CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1461145709000029
关键词
Lithium; post-transcription regulation; target gene
资金
- NIMH [MH064596, MH070775]
- Stanley Medical Research Institute (SMRI) Research
- Prechter Bipolar Genetics Fund at the University of Michigan Depression Center
- National Center for Integrative Biomedical Informatics [U54-DA-021519]
Lithium (Li) is commonly used in the treatment of bipolar disorder (131)). However, the molecular mechanism of its action is not completely understood. MicroRNAs (miRNAs), a class of small RNA species are recognized as important regulators in post-transcription gene expression. To explore the role of miRNAs in Li's action, we quantitatively analysed the expression patterns of 13 miRNAs in 20 lymphoblastoid cell lines (LCLs) with or without Li treatment in culture. Using paired t statistics in the analysis, we identified significant changes in seven of the 13 miRNAs tested in LCLs sampled at treatment day 4 (p<0.05). Four of the seven significant mRZNAs, miR-34a, miR-152, miR-155, and miR-221 consistently changed expression in the same LCLs at a longer treatment time-point, day 16 (Bonferroni p<0.05). Interestingly, miR-221 and miR-34a also changed expression in rat hippocampus in response to Li treatment (Zhou et al. 2008), although in the opposite direction. We focused on the predicted target mRNAs of miR-221 and miR-34a, and identified 29 and ten targets that were strongly and inversely correlated to expression with the two mRNAs, respectively. Our results suggest that miRNAs are excellent candidates for the study Of the molecular basis of Li's treatment action in cell systems such as lymphocytes given limited access to the human brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据